Security key
25056L103
Design Therapeutics, Inc. - Common Stock, par value $0.0001 per share (DSGN)
CUSIP: 25056L103
Q3 2025 13F Holders as of 30 Sep 2025
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 34,492,564
- Total 13F value
- $259,728,206
- Share change
- -39,040
- SEC-reported price per share
- $7.53
- Number of holders
- 94
- Value change
- +$644,093
- Number of buys
- 30
- Number of sells
- 49
- Shares outstanding
- 61,880,773
Holder snapshot
6 facts
Security identity
1 fact
Report period
Q3 2025
Institutions
94
Top holders
10
DSGN full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2025
Previous quarter: Q2 2025
Design Therapeutics, Inc. SEC filings
Design Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 25056L103
Recent filing periods:
Ownership snapshot
Top reported holders of DSGN - Design Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Light Irrevocable Trust #...
Disclosed value leader
SR ONE CAPITAL MANAGEMENT...
Comparable rows
15/15
Latest evidence
30 Jun 2025
13D/G
13F
Lead comparable stake: 6.9%
13D/G row: Light Irrevocable Trust #1 dated April 22, 2019
Showing 1-6 of 15 holder rows.
Quick read
Light Irrevocable Trust #1 dated April 22, 2019 leads the comparable SEC ownership view at 6.9%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
Light Irrevocable Trust #1 dated ...
6.9%
Star Irrevocable Trust #1 dated A...
6.9%
SR ONE CAPITAL MANAGEMENT, LP
11%
Logos Global Management LP
6.8%
BlackRock, Inc.
3.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Light Irrevocable Trust #1 dated April 22, 2019 |
13D/G
|
6.9%
|
$16,257,665
3,834,355 shares
|
$0 | 31 Dec 2024 |
| Star Irrevocable Trust #1 dated April 22, 2019 |
13D/G
|
6.9%
|
$16,257,665
3,834,355 shares
|
$0 | 31 Dec 2024 |
| SR ONE CAPITAL MANAGEMENT, LP |
13F
Company
|
11%
|
$21,994,224
6,526,476 shares
|
— | 30 Jun 2025 |
| Logos Global Management LP |
13F
Company
|
6.8%
|
$14,213,403
4,217,627 shares
|
— | 30 Jun 2025 |
| BlackRock, Inc. |
13F
Company
|
3.9%
|
$8,073,655
2,395,743 shares
|
— | 30 Jun 2025 |
| Frazier Life Sciences Management, L.P. |
13F
Company
|
3.2%
|
$6,583,453
1,953,547 shares
|
— | 30 Jun 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
94
Shares
34,492,564
Rows available
94
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
91
Q3 2025 holders
94
Holder diff
3
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 value | Q3 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend